U.S. Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use – Market Forecast, 2025–2034
Description
The U.S. hemostasis valve market size is expected to reach USD 116.33 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites.
The U.S. healthcare system is rapidly shifting toward minimally invasive surgery to reduce recovery time, hospital stays, and procedural complications. Interventional radiology and cardiology techniques are replacing traditional open surgeries, and these catheter-based approaches rely heavily on devices such as hemostasis valves to maintain blood control. The demand for tools that support these procedures is increasing as patient preference and healthcare policies favor less invasive care. Hemostasis valves are integral to ensuring both patient safety and procedural success in these fast-growing segments, making them a key component of the modern U.S. clinical toolkit and driving the U.S. hemostasis valve market market growth.
Medical institutions in the U.S. invest heavily in training programs and continuing education for healthcare professionals, especially in fields such as interventional cardiology, radiology, and endovascular surgery. These programs emphasize safe and efficient vascular access techniques, which include the use of hemostasis valves. The preference for high-quality valve solutions that improve procedural control and reduce complications such as blood loss and infection rise as clinical awareness grows. The educated and skilled medical workforce in the U.S. ensures high adoption rates of advanced medical devices and supports the ongoing expansion of the hemostasis valve market across various care settings.
U.S. Hemostasis Valve Market Report Highlights
In 2024, the hospital segment dominated with the largest share due to their advanced infrastructure, access to high patient volumes, and integration of interventional care units.
The angioplasty segment is expected to experience significant growth during the forecast period as angioplasty remains one of the most commonly performed interventional procedures in the U.S., especially for treating coronary artery disease.
A few key market players are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Boston Scientific Corporation; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.
Polaris Market Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:
By Type (Revenue - USD Million, 2020–2034)
Hemostasis Valve Y- Connectors
Double Y- Connector Hemostasis Valves
One- Handed Hemostasis Valves
Others
By Application (Revenue - USD Million, 2020–2034)
Angiography
Angioplasty
By End Use (Revenue - USD Million, 2020–2034)
Hospitals
Ambulatory Surgical Centers
Others
A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites.
The U.S. healthcare system is rapidly shifting toward minimally invasive surgery to reduce recovery time, hospital stays, and procedural complications. Interventional radiology and cardiology techniques are replacing traditional open surgeries, and these catheter-based approaches rely heavily on devices such as hemostasis valves to maintain blood control. The demand for tools that support these procedures is increasing as patient preference and healthcare policies favor less invasive care. Hemostasis valves are integral to ensuring both patient safety and procedural success in these fast-growing segments, making them a key component of the modern U.S. clinical toolkit and driving the U.S. hemostasis valve market market growth.
Medical institutions in the U.S. invest heavily in training programs and continuing education for healthcare professionals, especially in fields such as interventional cardiology, radiology, and endovascular surgery. These programs emphasize safe and efficient vascular access techniques, which include the use of hemostasis valves. The preference for high-quality valve solutions that improve procedural control and reduce complications such as blood loss and infection rise as clinical awareness grows. The educated and skilled medical workforce in the U.S. ensures high adoption rates of advanced medical devices and supports the ongoing expansion of the hemostasis valve market across various care settings.
U.S. Hemostasis Valve Market Report Highlights
In 2024, the hospital segment dominated with the largest share due to their advanced infrastructure, access to high patient volumes, and integration of interventional care units.
The angioplasty segment is expected to experience significant growth during the forecast period as angioplasty remains one of the most commonly performed interventional procedures in the U.S., especially for treating coronary artery disease.
A few key market players are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Boston Scientific Corporation; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.
Polaris Market Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:
By Type (Revenue - USD Million, 2020–2034)
Hemostasis Valve Y- Connectors
Double Y- Connector Hemostasis Valves
One- Handed Hemostasis Valves
Others
By Application (Revenue - USD Million, 2020–2034)
Angiography
Angioplasty
By End Use (Revenue - USD Million, 2020–2034)
Hospitals
Ambulatory Surgical Centers
Others
Table of Contents
129 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
